# Effects of Microcrystalline Titanium Dioxide With Covalently Linked Monovalent Silver Ions on Complications After Total Hysterectomy ( ISTIAB-0)

> **NCT03791294** · PHASE3 · UNKNOWN · sponsor: **Università degli Studi dell'Insubria** · enrollment: 200 (estimated)

## Conditions studied

- Infection
- Bleeding
- Complication, Postoperative

## Interventions

- **DRUG:** TIAB: microcrystalline titanium dioxide with covalently linked monovalent silver ions

## Key facts

- **NCT ID:** NCT03791294
- **Lead sponsor:** Università degli Studi dell'Insubria
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03791294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03791294, "Effects of Microcrystalline Titanium Dioxide With Covalently Linked Monovalent Silver Ions on Complications After Total Hysterectomy ( ISTIAB-0)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03791294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*